EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Uso hospitalario de inhibidores de la bomba de protones y antimicrobianos, y su asociación con el riesgo de infección por Clostridioides difficile: un enfoque de Farmacovigilancia

Yesenia Sánchez Lugo

Latin american journal of clinical sciences and medical technology · 24.07.2026 · 8 (1) · 86-99

DOI: 10.34141/ljcs3532768 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Latin american journal of clinical sciences and medical technology, erschienen am 24.07.2026. Verfasst von Yesenia Sánchez Lugo. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Clostridioides difficile infection (CDI) is the leading cause of healthcare - associated diarrhea and is strongly linked to pharmacological exposure, particularly antimicrobials and proton pump inhibitors (PPIs).

Objective

To evaluate the association between antimicrobial and PPI use and the risk of CDI in hospitalized patients. Materials and Methods. A retrospective observational analytical case - control study was conducted. A total of 60 hospitalized patients were included (30 cases with confirmed CDI and 30 controls without infection). Demographic, clinical, and pharmacological variables were analyzed. Associations between exposure factors and infection were estimated using crude odds ratios (OR) with 95 % confidence intervals (95 % CIs).

Results

Patients with CDI were older (52.61 ± 18.81 vs. 39.62 ± 16.98 years; p = 0.0036) and received more prescribed antibiotics (4.07 ± 2.29 vs. 2.00 ± 2.42; p = 0.0012). Polyantibiotic therapy (≥3 antibiotics) was significantly associated with CDI (OR: 6.57; 95 % CI: 2.11-20.48; p = 0.0016). Prolonged PPI use (≥7 days) was also significantly associated (OR: 4.57; 95 % CI: 1.45-14.39; p = 0.015). Carbapenem (56.7 % vs. 26.7 %; p = 0.036) and clindamycin use (26.7 % vs. 6.7 %; p = 0.034) were more frequent among cases, although these associations were not statistically significant in risk estimation.

Conclusions

Polyantibiotic therapy and prolonged PPI use were significantly associated with CDI. Antimicrobial exposure burden appears to be the main pharmacological determinant, while PPIs may act as a contributing factor. Incorporating CDI into pharmacovigilance systems may improve prescribing practices and enhance patient safety in hospital settings.

Zitieren

APA

Lugo, Y. S. (2026). Uso hospitalario de inhibidores de la bomba de protones y antimicrobianos, y su asociación con el riesgo de infección por Clostridioides difficile: un enfoque de Farmacovigilancia. Latin american journal of clinical sciences and medical technology, 8(1), 86-99. https://doi.org/10.34141/ljcs3532768

Vancouver

Lugo YS. Uso hospitalario de inhibidores de la bomba de protones y antimicrobianos, y su asociación con el riesgo de infección por Clostridioides difficile: un enfoque de Farmacovigilancia. Latin american journal of clinical sciences and medical technology. 2026;8(1):86-99. doi:10.34141/ljcs3532768

BibTeX
@article{Lugo2026,
  author = {Lugo, Yesenia Sánchez},
  title = {Uso hospitalario de inhibidores de la bomba de protones y antimicrobianos, y su asociación con el riesgo de infección por Clostridioides difficile: un enfoque de Farmacovigilancia},
  journal = {Latin american journal of clinical sciences and medical technology},
  year = {2026},
  volume = {8},
  number = {1},
  pages = {86--99},
  doi = {10.34141/ljcs3532768}
}
Kostenlos starten →